TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15284540

Group type: EXPERIMENTAL
Intervention: Digital ETCO2/Spo2 monitoring during paramedic rapid sequence intubation (RSI) using midazolam and succinylcholine; rocuronium administered after confirmation of tube position.
Number of subjects: 426

Group type: COMPARATOR
Intervention: Matched controls (historical nonintubated controls).
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Digital ETCO2/Spo2 monitoring during paramedic rapid sequence intubation (RSI).
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Digital ETCO2/Spo2 monitoring during paramedic RSI.
Number of subjects: 426
Study: 11300330

Group type: EXPERIMENTAL
Intervention: Anthracycline-based first-line chemotherapy
Number of subjects: 1430
Study: 10224737

Group type: EXPERIMENTAL
Intervention: Behavioral choice treatment (BCT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Traditional behavioral treatment (TBT)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 1839490

Group type: EXPERIMENTAL
Intervention: Teicoplanin (6 mg/kg q24h i.v. after initial loading at 6 mg/kg q12h for three doses)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Vancomycin (15 mg/kg q12h i.v.)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Teicoplanin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Vancomycin and cyclosporin A
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Teicoplanin and cyclosporin A
Number of subjects: 50

Group type: COMPARATOR
Intervention: Vancomycin and amphotericin B
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Teicoplanin and amphotericin B
Number of subjects: 50
Study: 6476854

Group type: EXPERIMENTAL
Intervention: PUVA-UV-B therapy administered twice weekly
Number of subjects: 21

Group type: COMPARATOR
Intervention: Lower doses of PUVA and UV-B
Number of subjects: 21
Study: 31051059

Group type: EXPERIMENTAL
Intervention: HBO2 therapy
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control (no HBO2 therapy)
Number of subjects: 115
Study: 29314138

Group type: EXPERIMENTAL
Intervention: Lower insulin dosages
Number of subjects: 187

Group type: COMPARATOR
Intervention: Irregular menses
Number of subjects: 187

Group type: COMPARATOR
Intervention: Diabetes-specific variables
Number of subjects: 187
Study: 26965763

Group type: EXPERIMENTAL
Intervention: Folic acid fortified milk (FM) providing 400 μg folic acid per day
Number of subjects: 70

Group type: COMPARATOR
Intervention: Unfortified placebo milk (PM)
Number of subjects: 70
Study: 23681403

Group type: EXPERIMENTAL
Intervention: Standard adjuvant chemotherapy (cyclophosphamide-methotrexate-5-fluorouracil or doxorubicin-cyclophosphamide)
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Capecitabine
Number of subjects: 297

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 297
Study: 21285003

Group type: EXPERIMENTAL
Intervention: Accessory mobilisation technique
Number of subjects: 13

Group type: COMPARATOR
Intervention: Manual contact control
Number of subjects: 13

Group type: COMPARATOR
Intervention: No contact control
Number of subjects: 13
Study: 19835125

Group type: EXPERIMENTAL
Intervention: Zhongzhu (TE 3) group
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Yanglingquan (GB 34) group
Number of subjects: 42
Study: 17454341

Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 15480981

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg twice a day plus omeprazole placebo once daily
Number of subjects: 287

Group type: COMPARATOR
Intervention: Diclofenac 75 mg twice daily plus omeprazole 20 mg once daily
Number of subjects: 287
Study: 11530400

Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Low energetic laser irradiation
Number of subjects: 57
Study: 10636525

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulphate (2 g over 5 min followed by 16 g over 24 h)
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulphate
Number of subjects: 350
Study: 7924475

Group type: EXPERIMENTAL
Intervention: Intravenous aminophylline (loading dose followed by infusion)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo (equal volume as loading dose and infusion)
Number of subjects: 94
Study: 2810182

Group type: EXPERIMENTAL
Intervention: Polybutester (Novafil)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Polypropylene
Number of subjects: 77
Study: 1107883

Group type: EXPERIMENTAL
Intervention: Propranolol 120 mg daily
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 21
Study: 31336055

Group type: EXPERIMENTAL
Intervention: Speechreading training
Number of subjects: 66

Group type: COMPARATOR
Intervention: Maths training
Number of subjects: 66
Study: 28466660

Group type: EXPERIMENTAL
Intervention: Percutaneous polidocanol injection (PPI)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Aspiration
Number of subjects: 111
Study: 26307518

Group type: EXPERIMENTAL
Intervention: Dietary protocol (D)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Running program (R)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both dietary and running protocols (R&D)
Number of subjects: 45
Study: 23496876

Group type: EXPERIMENTAL
Intervention: Lumbar spinal manipulation therapy (SMT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no SMT)
Number of subjects: 60
Study: 21518837

Group type: EXPERIMENTAL
Intervention: Intravenous linezolid at 600 mg twice daily
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oral linezolid at 600 mg twice daily
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Thrice-daily dosing of intravenous linezolid
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Thrice-daily dosing of oral linezolid
Number of subjects: 8
Study: 17876492

Group type: EXPERIMENTAL
Intervention: Ability to contract pelvic floor muscles voluntarily
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Involuntary contraction of pelvic floor muscles
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Correlation with previous PFM training
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Correlation with number of childbirths and BMI
Number of subjects: 343
Study: 16585311

Group type: EXPERIMENTAL
Intervention: Distraction techniques during laceration repair
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (no distraction techniques)
Number of subjects: 240
Study: 12920413

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11049764

Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 0
Study: 9596908

Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol (100 micrograms)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 8122021

Group type: EXPERIMENTAL
Intervention: Powdered terbutaline (500 microgram) via Bricanyl Turbuhaler
Number of subjects: 30

Group type: COMPARATOR
Intervention: Metered dose aerosol (Nebuhaler)
Number of subjects: 30
Study: 3298069

Group type: EXPERIMENTAL
Intervention: High doses of anti-lipid A
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 17
Study: 29474007

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 28691254

Group type: EXPERIMENTAL
Intervention: Phonics-based intervention for children with dyslexia
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group of 93 typical readers
Number of subjects: 80
Study: 26291338

Group type: EXPERIMENTAL
Intervention: Minimally invasive SIJ fusion with triangular titanium implants
Number of subjects: 148

Group type: COMPARATOR
Intervention: Nonsurgical management
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Crossover from nonsurgical to surgical treatment
Number of subjects: 148
Study: 23073336

Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 21493747

Group type: EXPERIMENTAL
Intervention: IMT at 80% of sustained maximum inspiratory effort
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: IMT at 60% of sustained maximum inspiratory effort
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: IMT at 40% of sustained maximum inspiratory effort
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 40
Study: 18565369

Group type: EXPERIMENTAL
Intervention: Stepwise excavation over 2 visits
Number of subjects: 0

Group type: COMPARATOR
Intervention: Complete excavation of deep caries
Number of subjects: 0
Study: 16439047

Group type: EXPERIMENTAL
Intervention: F (226 microg F/ml as NaF)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: F+X:S (xylitol:sorbitol 1:3; final concentration 1.6M; 28% of sugar alcohols)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Distilled and deionized water (negative control)
Number of subjects: 10
Study: 12548082

Group type: EXPERIMENTAL
Intervention: simvastatin 80 mg/d
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: atorvastatin 40 mg/d
Number of subjects: 48

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 48
Study: 10911780

Group type: EXPERIMENTAL
Intervention: Iopamidol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mannitol (equiosmolar solution)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.9 N Saline solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 0
Study: 9124806

Group type: EXPERIMENTAL
Intervention: Presence of extrahippocampal structural abnormalities
Number of subjects: 27

Group type: COMPARATOR
Intervention: Absence of extrahippocampal structural abnormalities
Number of subjects: 27
Study: 8411458

Group type: EXPERIMENTAL
Intervention: Norfloxacin prophylaxis for 15 days following catheter removal
Number of subjects: 265

Group type: COMPARATOR
Intervention: No antimicrobial prophylaxis
Number of subjects: 265
Study: 3891203

Group type: EXPERIMENTAL
Intervention: Moxalactam disodium 2 g every 12 hours
Number of subjects: 50

Group type: COMPARATOR
Intervention: Gentamicin (3-5 mg/kg/day in three divided doses) and clindamycin phosphate 600 mg every six hours
Number of subjects: 50
Study: 29032078

Group type: EXPERIMENTAL
Intervention: Pasireotide 10 mg every 4 weeks for 12 months
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Pasireotide 30 mg every 4 weeks for 12 months
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Pasireotide 10 mg
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Pasireotide 30 mg
Number of subjects: 150
Study: 26940161

Group type: EXPERIMENTAL
Intervention: BBFC+TRAV
Number of subjects: 233

Group type: COMPARATOR
Intervention: vehicle+TRAV
Number of subjects: 233
Study: 24906587

Group type: EXPERIMENTAL
Intervention: D&G preparation (two capsules daily)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo (two capsules daily)
Number of subjects: 165
Study: 23123256

Group type: EXPERIMENTAL
Intervention: Minor neurological dysfunction (MND) - fine manipulative disability
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Minor neurological dysfunction (MND) - coordination problems
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Coordination problems in girls
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Coordination problems in boys
Number of subjects: 341
Study: 20864564

Group type: EXPERIMENTAL
Intervention: Resistive vibration exercise (n = 7)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Resistive exercise only (n = 8)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No exercise (control group, n = 9)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Resistive vibration exercise vs. control
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Countermeasures (both exercise groups)
Number of subjects: 24
Study: 18479954

Group type: EXPERIMENTAL
Intervention: Once-daily administration of inhaled glucocorticosteroids
Number of subjects: 24

Group type: COMPARATOR
Intervention: Twice-daily administration of inhaled glucocorticosteroids
Number of subjects: 24
Study: 15905346

Group type: EXPERIMENTAL
Intervention: Active thermoregulation
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control (no active thermoregulation)
Number of subjects: 69
Study: 12683560

Group type: EXPERIMENTAL
Intervention: Low-energy cardioversion (LEC)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 48
Study: 10525224

Group type: EXPERIMENTAL
Intervention: Primary stent implantation (STENT group)
Number of subjects: 136
Study: 8712442

Group type: EXPERIMENTAL
Intervention: 0.05 microgram/kg isoproterenol
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 0.075 microgram/kg isoproterenol
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 0.1 microgram/kg isoproterenol
Number of subjects: 72

Group type: COMPARATOR
Intervention: 0.25 mg/kg bupivacaine and saline
Number of subjects: 72
Study: 1951831

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6159698

Group type: EXPERIMENTAL
Intervention: Twice per week radiotherapy (2 fractions per week)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Five times per week radiotherapy (conventional regime)
Number of subjects: 250
Study: 31722102

Group type: EXPERIMENTAL
Intervention: Faculty Development (FD) program, monthly half-day in-class sessions for 20 months
Number of subjects: 33

Group type: COMPARATOR
Intervention: Matched controls (nonparticipants)
Number of subjects: 33
Study: 29493167

Group type: EXPERIMENTAL
Intervention: Distress Thermometer (DT) with a cutoff score of 3
Number of subjects: 836

Group type: EXPERIMENTAL
Intervention: Diagnosis within 1–4 weeks prior to assessment
Number of subjects: 836
Study: 25527737

Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (RT)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Resistance Training with Supplementation (RTS)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Cognitive Training (CT)
Number of subjects: 105
Study: 24153026

Group type: EXPERIMENTAL
Intervention: London Stroke Carer Training Course (LSCTC)
Number of subjects: 930

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 930
Study: 21338481

Group type: COMPARATOR
Intervention: Placebo surgery (three small incisions)
Number of subjects: 49

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Arthroscopic lavage
Number of subjects: 49
Study: 19775039

Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg ketamine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All groups (0.15 mg/kg ketamine, 0.5 mg/kg ketamine, normal saline)
Number of subjects: 120
Study: 16923362

Group type: EXPERIMENTAL
Intervention: Intravenous ambroxol (15 mg/kg immediately after birth, then 30 mg/kg daily for 2 days)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Atomizing ambroxol (30 mg/kg daily for 2 days)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control (no ambroxol treatment)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Intravenous ambroxol
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Atomizing ambroxol
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Intravenous ambroxol and Atomizing ambroxol
Number of subjects: 125
Study: 15016039

Group type: EXPERIMENTAL
Intervention: Full-mouth scaling and root planing (FM-SRP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Quadrant scaling and root planing (Q-SRP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Q-SRP (remaining untreated quadrants)
Number of subjects: 40
Study: 11762561

Group type: EXPERIMENTAL
Intervention: 80 mg eletriptan during phase 1 (menses), days 1 to 4
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 80 mg eletriptan during phase 2 (follicular), days 6 to 10
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 80 mg eletriptan during phase 3 (ovulatory), days 11 to 13
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 80 mg eletriptan during phase 4 (luteal), days 21 to 24
Number of subjects: 16
Study: 10322845

Group type: EXPERIMENTAL
Intervention: Jiawei Dachaihu decoction (group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (group A)
Number of subjects: 40
Study: 7679040

Group type: EXPERIMENTAL
Intervention: Radiation therapy (doses of 60-65 Gy)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Pelvic irradiation
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Local irradiation
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Reirradiation (brachytherapy combined with hyperthermia)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: External irradiation for bony metastasis
Number of subjects: 47

Group type: COMPARATOR
Intervention: Elective hemibody irradiation
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Radioactive phosphorus-32 or strontium-89
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Irradiation for spinal cord compression
Number of subjects: 47
Study: 3799501

Group type: EXPERIMENTAL
Intervention: Postpartum WIC supplementation for 5-7 months
Number of subjects: 703

Group type: COMPARATOR
Intervention: Postpartum benefits for 0-2 months (Control)
Number of subjects: 703
Study: 31854251

Group type: EXPERIMENTAL
Intervention: Child-Centred Health Dialogue
Number of subjects: 785

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 785
Study: 31612723

Group type: EXPERIMENTAL
Intervention: Sufentanil Sublingual Tablet System (SSTS)
Number of subjects: 341
Study: 28714534

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Adjustable Thermoplastic Mandibular Advancement Splint (AT-MAS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 50

Group type: COMPARATOR
Intervention: AT-MAS
Number of subjects: 50
Study: 25761833

Group type: EXPERIMENTAL
Intervention: Androgen replacement therapy (ART)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Control
Number of subjects: 334
Study: 24486335

Group type: EXPERIMENTAL
Intervention: Subcutaneous ondansetron 4 mg + rHuPH20
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intramuscular ondansetron 4 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intravenous ondansetron 4 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Oral ondansetron 8 mg
Number of subjects: 12
Study: 24570527

Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopic debridement
Number of subjects: 40

Group type: COMPARATOR
Intervention: Antibiotic therapy and irrigation
Number of subjects: 40
Study: 20527340

Group type: EXPERIMENTAL
Intervention: 5 mg of 0.25% bupivacaine with saline EVE (n=51)
Number of subjects: 157

Group type: COMPARATOR
Intervention: 5 mg of 0.25% bupivacaine without saline EVE (n=6)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: 5 mg of 0.25% L-bupivacaine (n=50)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: 6 mg of 0.3% L-bupivacaine (n=50)
Number of subjects: 157
Study: 18785569

Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopic surgery (VATS)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Mini-thoracotomy (MT)
Number of subjects: 47
Study: 16134467

Group type: EXPERIMENTAL
Intervention: Early treatment for high-risk prethreshold ROP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 12641681

Group type: EXPERIMENTAL
Intervention: midazolam/Syrpalta mixture
Number of subjects: 76

Group type: COMPARATOR
Intervention: premixed midazolam solution
Number of subjects: 76
Study: 10378492

Group type: EXPERIMENTAL
Intervention: Nonimmersive VR exercise
Number of subjects: 13

Group type: COMPARATOR
Intervention: Single bout of VR exercise
Number of subjects: 13
Study: 9007599

Group type: EXPERIMENTAL
Intervention: Meropenem 1 g intravenously every 8 h
Number of subjects: 61

Group type: COMPARATOR
Intervention: Imipenem/cilastatin 1 g intravenously every 8 h
Number of subjects: 61
Study: 1501736

Group type: EXPERIMENTAL
Intervention: Reduced glutathione (1,200 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6663618

Group type: EXPERIMENTAL
Intervention: Visual proportional feedback
Number of subjects: 20

Group type: COMPARATOR
Intervention: Visual binary feedback
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Auditory proportional feedback
Number of subjects: 20

Group type: COMPARATOR
Intervention: Auditory binary feedback
Number of subjects: 20
Study: 31647007

Group type: EXPERIMENTAL
Intervention: Dimeticone-based test product (10 min application)
Number of subjects: 100

Group type: COMPARATOR
Intervention: 0.5% permethrin-based reference product (45 min application)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both groups (Dimeticone and Permethrin)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dimeticone-based test product
Number of subjects: 100
Study: 28019051

Group type: EXPERIMENTAL
Intervention: Remote monitoring (RM)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Traditional follow-up model
Number of subjects: 600
Study: 25599428

Group type: EXPERIMENTAL
Intervention: Feldenkrais method-based exercise (50 sessions, 2 times/week for 60 minutes)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Educational lectures (control group)
Number of subjects: 30
Study: 23980044

Group type: EXPERIMENTAL
Intervention: Intermittent Pneumatic Compression (IPC)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (non-IPC group)
Number of subjects: 120
Study: 21422438

Group type: EXPERIMENTAL
Intervention: Vitamin D deficiency (defined as 25(OH)D lower than 20 ng/mL)
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Vitamin D insufficiency (defined as 25(OH)D between 20 to 29 ng/mL)
Number of subjects: 515

Group type: COMPARATOR
Intervention: Comparison of plasma 25(OH)D levels by race
Number of subjects: 515

Group type: COMPARATOR
Intervention: Comparison of plasma 25(OH)D levels by gender
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Baseline plasma 25(OH)D levels
Number of subjects: 515
Study: 19661049

Group type: EXPERIMENTAL
Intervention: 30% oxygen
Number of subjects: 78

Group type: COMPARATOR
Intervention: 90% oxygen
Number of subjects: 78